Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

Antibody-based HIV Prevention: Preparing for Success

October 22, 2018

New partnership aims to make antibody prophylaxis for HIV more feasible and affordable.

Read more

Press Releases

IAVI and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products for HIV

October 22, 2018

Collaboration to develop optimal combination of HIV-specific antibodies and ensure that cost is not a barrier to access.

Read more

In The News

Why HIV vaccine research is now about much more than HIV

October 17, 2018

Read more

Scientific Publications

Design display and immunogenicity of HIV1 gp120 fragment immunogens on virus like particles

Read more

Press Releases

IAVI Announces Clinical Trial of Next-Generation HIV Vaccine Candidate Designed to Induce Antibodies to Block HIV Infection

October 8, 2018

Phase I trial to evaluate safety and immunogenicity of vaccine candidate engineered to elicit targeted immune response against HIV.

Read more

Scientific Publications

Characterization of the membrane bound form of the chimeric B C recombinant HIV 1 Env LT5 J4b12C

Read more

Press Releases

IAVI Acquires Aeras TB Vaccine Clinical Programs and Assets

October 1, 2018

Data from two Phase II clinical trials conducted by Aeras and partners indicate promise for future of TB vaccine development.

Read more

Features

Scientific Advances Spur New Hope for Defeating TB

October 1, 2018

After decades of research, renewed promise emerges for developing vaccines against the world’s deadliest infectious disease.

Read more